Article
Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.
Journal of clinical immunology - 6 Jan 2025
Walsh Rebecca B, McNaughton Peter, Nademi Zohreh, Laberko Alexandra, Balashov Dmitry, Al-Mousa Hamoud, Arkwright Peter D, Wynn Robert F, Flood Terry, Williams Eleri, Cant Andrew, Abinun Mario, Hambleton Sophie, Slatter Mary, Gennery Andrew R, Lum Su Han, Owens Stephen
Abstract excerpt
Receptor Interacting Serine/Threonine Kinase 1 (RIPK1) is widely expressed and integral to inflammatory and cell death responses. Autosomal recessive RIPK1-deficiency, due to biallelic loss of function mutations in RIPK1, is a rare inborn error of immunity (IEI) resulting in uncontrolled necroptosis, apoptosis and inflammation. Although hematopoietic stem cell transplantation (HSCT) has been suggested as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
